Sandi Deans, UK NEQAS, Discusses the Need for Patient-like Materials
With medical laboratory standards being more closely scrutinized, UK NEQAS turns to SeraCare to aide in their awareness of sensitivity, specificity, and accuracy in limit of detection. Sandi Deans, PhD, Director for Molecular Genetics and Molecular Pathology, explains why she chooses SeraCare’s liquid biopsy reference standards in their external quality assessment schemes.
SeraCare has been fantastic in helping us develop the plasma-based EQA schemes. Technically that’s very challenging to deliver as an EQA provider; it’s not an easy sample type to be able to just get on tap from any patient or bio bank. – Sandi Deans, PhD
Watch this video to learn more about how UK NEQAS overcomes the challenges of sourcing material that’s scalable, reliable, and able to be transported globally.
See what others are saying about SeraCare by visiting our Customer Stories.
Related Content
Asuragen
Why Asuragen Chooses Seraseq® ctDNA v2
Asuragen relies on SeraCare’s liquid biopsy products to help streamline sensitive assays and workflows in order to produce high-quality results. Associate Director of Bioinformatics at Asuragen, Brian Haynes, PhD, talks about the importance of high-quality, patient-like reference materials and LOD experiments.
MD Anderson Cancer Center
Reference Materials Prove Instrumental for MD Anderson Cancer Center Lab
SeraCare’s reference materials give Jawad Manekia, PhD, supervisor of a molecular diagnostics laboratory at MD Anderson Cancer Center, the confidence he needs to be able to report that an assay passes quality control.
University of Illinois
iQ NGS QC Management Transforms Genomic Medicine Lab at the University of Illinois
Working in a lab with major focuses of clinical diagnostics and translational research, Gayatry Mohapatra, PhD, understands the needs for high-quality software to help with data management.